Indivior

CompanyUnited StatesFounded 1994

ROR

Indivior develops 6 assets, the furthest approved (naloxone hydrochloride in opioid overdose). Mostly small molecule acting on OPRM1, OPRK1 and OPRD1; based in the United States, founded in 1994.

6
Assets
Furthest stage
Approved
31
Trials
26
Signals

Pipeline

6
  • naloxone hydrochloride

    Blocks opioid receptors, reversing opioid-mediated effects.

    Approved, Small molecule, OPRM1, OPRK1, opioid overdose, overdose

  • OPVEE

    Approved

  • SUBLOCADE

    Provides extended-release buprenorphine by subcutaneous injection.

    Approved, OPRM1, OPRK1, opioid use disorder, Moderate to Severe Opioid Use Disorder

3 more assets

Full company profiles: pipeline, trials, funding and people.

See Pro

In the full profile

  • Evidence behind the mechanisms6
  • Trials33
  • People1
  • Signals20
  • Similar companies6

Intelligence